Kelly Vincent P, Sherratt Philip J, Crouch Dorothy H, Hayes John D
Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Scotland, UK.
Biochem J. 2002 Sep 15;366(Pt 3):847-61. doi: 10.1042/BJ20020342.
The aldo-keto reductase (AKR) 7 family is composed of the dimeric aflatoxin B(1) aldehyde reductase (AFAR) isoenzymes. In the rat, two AFAR subunits exist, designated rAFAR1 and rAFAR2. Herein, we report the molecular cloning of rAFAR2, showing that it shares 76% sequence identity with rAFAR1. By contrast with rAFAR1, which comprises 327 amino acids, rAFAR2 contains 367 amino acids. The 40 extra residues in rAFAR2 are located at the N-terminus of the polypeptide as an Arg-rich domain that may form an amphipathic alpha-helical structure. Protein purification and Western blotting have shown that the two AFAR subunits are found in rat liver extracts as both homodimers and as a heterodimer. Reductase activity in rat liver towards 2-carboxybenzaldehyde (CBA) was resolved by anion-exchange chromatography into three peaks containing rAFAR1-1, rAFAR1-2 and rAFAR2-2 dimers. These isoenzymes are functionally distinct; with NADPH as cofactor, rAFAR1-1 has a low K(m) and high activity with CBA, whereas rAFAR2-2 exhibits a low K(m) and high activity towards succinic semialdehyde. These data suggest that rAFAR1-1 is a detoxication enzyme, while rAFAR2-2 serves to synthesize the endogenous neuromodulator gamma-hydroxybutyrate (GHB). Subcellular fractionation of liver extracts showed that rAFAR1-1 was recovered in the cytosol whereas rAFAR2-2 was associated with the Golgi apparatus. The distinct subcellular localization of the rAFAR1 and rAFAR2 subunits was confirmed by immunocytochemistry in H4IIE cells. Association of rAFAR2-2 with the Golgi apparatus presumably facilitates secretion of GHB, and the novel N-terminal domain may either determine the targeting of the enzyme to the Golgi or regulate the secretory process. A murine AKR protein of 367 residues has been identified in expressed sequence tag databases that shares 91% sequence identity with rAFAR2 and contains the Arg-rich extended N-terminus of 40 amino acids. Further bioinformatic evidence is presented that full-length human AKR7A2 is composed of 359 amino acids and also possesses an additional N-terminal domain. On the basis of these observations, we conclude that AKR7 proteins can be divided into two subfamilies, one of which is a Golgi-associated GHB synthase with a unique, previously unrecognized, N-terminal domain that is absent from other AKR proteins.
醛糖酮还原酶(AKR)7家族由二聚体黄曲霉毒素B(1)醛还原酶(AFAR)同工酶组成。在大鼠中,存在两种AFAR亚基,分别命名为rAFAR1和rAFAR2。在此,我们报告rAFAR2的分子克隆,结果表明它与rAFAR1具有76%的序列同一性。与包含327个氨基酸的rAFAR1不同,rAFAR2含有367个氨基酸。rAFAR2中额外的40个残基位于多肽的N端,形成一个富含精氨酸的结构域,可能构成两亲性α螺旋结构。蛋白质纯化和蛋白质印迹分析表明,在大鼠肝脏提取物中发现的这两种AFAR亚基既以同二聚体形式存在,也以异二聚体形式存在。大鼠肝脏中针对2-羧基苯甲醛(CBA)的还原酶活性通过阴离子交换色谱法解析为三个峰,分别含有rAFAR1-1、rAFAR1-2和rAFAR2-2二聚体。这些同工酶在功能上有所不同;以NADPH作为辅因子时,rAFAR1-1对CBA具有低K(m)值和高活性,而rAFAR2-2对琥珀酸半醛表现出低K(m)值和高活性。这些数据表明,rAFAR1-1是一种解毒酶,而rAFAR2-2用于合成内源性神经调节剂γ-羟基丁酸(GHB)。肝脏提取物的亚细胞分级分离显示,rAFAR1-1存在于细胞质中,而rAFAR2-2与高尔基体相关。在H4IIE细胞中通过免疫细胞化学证实了rAFAR1和rAFAR2亚基在亚细胞定位上的差异。rAFAR2-2与高尔基体的结合可能有助于GHB的分泌,而新的N端结构域可能决定该酶靶向高尔基体或调节分泌过程。在表达序列标签数据库中鉴定出一种含有367个残基的小鼠AKR蛋白,它与rAFAR2具有91%的序列同一性,并含有40个氨基酸的富含精氨酸的延伸N端。进一步的生物信息学证据表明,全长人AKR7A2由359个氨基酸组成,也具有一个额外的N端结构域。基于这些观察结果,我们得出结论,AKR7蛋白可分为两个亚家族,其中一个是与高尔基体相关的GHB合酶,具有一个独特的、以前未被识别的N端结构域,其他AKR蛋白中不存在该结构域。